Results 11 to 20 of about 9,594 (241)
Background Creutzfeldt-Jakob disease (CJD) is a rare, fatal, neurodegenerative prion disease potentially transmissible through corneal transplantation.
Majid Moshirfar +2 more
exaly +2 more sources
In March 1996 the discovery of a new form of Creutzfeldt-Jakob disease (CJD) was announced to a shocked world. In order to understand why this news took the headlines by storm, it is necessary to trace the history of this rare disease and in particular its links with bovine spongiform encephalopathy (BSE), or “mad cow disease”.
Jeanne E. Bell
openalex +3 more sources
Canadian Creutzfeldt-Jakob disease incidence remained stable during the coronavirus disease (COVID-19) pandemic. [PDF]
IntroductionHealthcare disruptions imposed by the coronavirus disease (COVID-19) pandemic and possible biological links between SARS-CoV-2 and prion misfolding might influence the prevalence or characteristics of Creutzfeldt-Jakob Disease (CJD).
Slota JA +11 more
europepmc +2 more sources
Is there a link between COVID-19 and Creutzfeldt-Jakob Disease? a Case Report [PDF]
Creutzfeldt-Jakob Disease (CJD) is a rare rapidly progressive neurodegenerative disease. The diagnosis of CJD is based on magnetic resonance imaging (MRI) findings, electro-encephalography (EEG), or 14-3-3 protein detection.
Ehsan Nasiri +3 more
doaj +1 more source
Bleach Usage for CJD Disinfection [PDF]
Andrea Scheidt
openalex +3 more sources
Sodium hypochlorite inactivation of human CJD prions
Prion diseases are transmissible, fatal neurologic diseases of mammals caused by the accumulation of mis-folded, disease associated prion protein (PrPd).
Bradley R. Groveman +3 more
openalex +2 more sources
Background: CSF total-tau (t-tau) became a standard cerebrospinal fluid biomarker in Alzheimer’s disease (AD). In parallel, extremely elevated levels were observed in Creutzfeldt-Jakob disease (CJD).
Peter Hermann +6 more
doaj +1 more source
Background Rapidly progressive forms of Alzheimer’s disease (rpAD) are increasingly recognized and may have a prevalence of up to 30% of patients among all patients with Alzheimer’s disease (AD).
Janne Marieke Herden +14 more
doaj +1 more source

